|
United States Government Children in Adversity Working Group (APCCA WG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, ACF
|
NICHD, FIC, NIEHS, NIMH
|
The United States Government (USG) Children in Adversity Working Group (WG) is a United States Agency for International Development (USAID)-led, USG-wide working group aimed at coordinating USG activities focused on at-risk children globally in accordance with Public Law 109-95.
|
|
United States Government Global Nutrition Coordination Plan
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NICHD
|
The purpose of the US Government Global Nutrition Coordination Plan is to strengthen the impact of the many diverse nutrition investments across the US Government through better communication and collaboration and through linking research to program implementation. Through coordination mechanisms, the US Government will maximize its support to country-led programs, continue its global leadership and partnerships, and generate, share, and apply knowledge and evidence in the nutrition sector in order to accelerate progress toward shared nutrition goals. The US Government is committed to improving nutrition throughout the world in order to enhance health, productivity, and human potential.
|
|
United States Government SARS-CoV-2 Interagency Group (SIG), Genomic Surveillance and Bioinformatics Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
NLM, NIAID
|
Interagency working group tasked with reviewing current SARS-CoV-2 genetic surveillance data and applicability of data to public health decisions.
|
|
Urine biomarkers and risk of lung cancer in the Sisters Study
|
Research Initiative
|
CDC, FDA
|
NCI
|
The National Cancer Institute (NCI) is using urine samples from the Sisters study cohort National Institute of Environmental Health Sciences (NIEHS) and the laboratory resources of the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) funding to examine urine biomarkers of tobacco exposure and risk of lung cancer in a prospective study.
|
|
Urine biomarkers of tobacco and opium and risk of cancers and heart disease
|
Research Initiative
|
CDC, FDA
|
NCI
|
The National Cancer Institute (NCI) is using urine samples from the Golestan Cohort Study and the laboratory resources of the Centers for Disease Control and Prevention (CDC) and partial Food and Drug Administration (FDA) funding to examine urine biomarkers of tobacco and opium exposure and risk of several cancers, heart disease, and lung disease.
|
|
US Government Health Agencies' Efforts to Address HIV-Related Intersectional Stigma
|
Other
|
CDC, HRSA, IHS, OASH, SAMHSA
|
OD/DPCPSI/OAR, NIMH
|
Editorial published in American Journal of Public Health in June 2022 on HIV-related intersectional stigma. Authors included staff from CDC, NIH, HRSA, IHS, and OASH, and SAMHSA.
|
|
US Preventive Services Task Force (USPSTF)
|
Resource Development
|
AHRQ, CDC, CMS, HRSA, IHS, OASH, FDA, SAMHSA
|
OD/DPCPSI/ODP, NCI
|
The US Preventive Services Task Force (USPSTF) is an independent panel of non-Federal experts in prevention and evidence-based medicine. The USPSTF uses information from systematic evidence reviews to make recommendations for a broad range of clinical preventive health care services (such as screening, counseling, and preventive medications) that are delivered in or referred from primary care practice. USPSTF recommendations are developed for primary care clinicians, health systems, and policy-makers, and published in the form of "Recommendation Statements." The Agency for Healthcare Research and Quality (AHRQ) has been authorized by the US Congress to convene the Task Force and to provide ongoing scientific, administrative, and dissemination support to the Task Force. The NIH Office of Disease Prevention (ODP) works closely with AHRQ and the USPSTF to provide scientific input from NIH Institutes and Centers on draft research plans, draft evidence reviews, and draft recommendation statements. The ODP also disseminates information to NIH Institutes and Centers about high-priority evidence gaps for clinical preventive services that have been identified by the USPSTF.
|
|
US Public Health Service (USPHS) Physicians Professional Advisory Committee (PPAC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, ATSDR, BARDA, CDC, CMS, FDA, HRSA, IHS, OS, Office of the Surgeon General (OSC), SAMHSA
|
NIAID
|
The purpose of this committee is to provide advice and consultation to the Surgeon General on issues relating to the professional practice and personnel activities, civil service, and Commissioned Corps of the Medical Category. The committee provides advisory assistance to the Chief Professional Officer and to the Agency and/or Program Heads of the USPHS and to non-PHS programs that routinely use USPHS personnel.
|
|
USDA-HHS Birth to 24 Months Pregnant Women Project Federal Expert Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NHLBI, NCI, NICHD, NIDDK, OD/DPCPSI/OBSSR
|
The current work includes identifying topics of public health importance and conducting a small number of systematic reviews on diet and health for infants, toddlers, and women who are pregnant; it will not include specific dietary recommendations or advice. The scientific basis for dietary guidance for these population groups will be informed by the advisory report of the next (2020) Dietary Guidelines Advisory Committee.
|
|
Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum
|
Research Initiative
|
CDC
|
NIMH
|
The Centers for Disease Control and Prevention (CDC) and the National Institute of Mental Health (NIMH) have established a cooperative agreement titled Using Real-time Prescription and Insurance Claims Data to Support the HIV Care Continuum (CDC RFA-PS-19-003). The purpose of the cooperative agreement is to develop, implement, and evaluate an "insurance-based data-to-care (D2C)" model. The insurance-based D2C model will start with Medicaid claims (diagnosis and procedure) to identify persons with diagnosed HIV, and then use real-time Medicaid claims data to determine whether these individuals have current antiretroviral (ARV) prescriptions. Persons with HIV who show lapsed ARV medications will receive a set of escalating adherence, retention, and re-linkage interventions. The research study will test the effectiveness of the approach (on viral suppression) as well as the cost-effectiveness of the approach.
|